Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma

Leuk Lymphoma. 2018 Jan;59(1):221-224. doi: 10.1080/10428194.2017.1320713. Epub 2017 May 30.

¹ a Department of Medicine , Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center , New York , NY , USA.
² b Providence Cancer Center, Earle A. Chiles Research Institute Portland , OR , USA.
³ c Hematology/Oncology Division , Oregon Health and Science University , Portland , OR , USA.
⁴ d Division of Hematology, Mayo Clinic Cancer Center , Hematologic Malignancies Program, Center for Immunology and Immune Therapies , Rochester , MN , USA.
⁵ e Hematologic Malignancies Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine , Baltimore , MD , USA.
⁶ f John Theurer Cancer Center, Hackensack University Medical Center , Hackensack , NJ , USA.

No abstract available

Publication types